Suppr超能文献

优化高危头颈部鳞状细胞癌的预后评估:肿瘤芽生和一种新型组织形态学评分系统的影响

Optimizing Prognostic Assessment in High-Risk Head and Neck Squamous Cell Carcinomas: The Impact of Tumor Budding and a Novel Histomorphological Scoring System.

作者信息

Knebel Moritz, Philipp Kühn Jan, Körner Sandrina, Braun Felix, Brust Lukas, Wemmert Silke, Smola Sigrun, Ertz Martin, Wagner Mathias, Schick Bernhard, Morris Luc G T, Linxweiler Maximilian, Klamminger Gilbert Georg

机构信息

Institute of Otorhinolaryngology, Saarland University, Homburg, Germany.

Department of Otorhinolaryngology, Head and Neck Surgery, Saarland University Medical Center (UKS), Homburg, Germany.

出版信息

Cancer Med. 2025 Feb;14(4):e70685. doi: 10.1002/cam4.70685.

Abstract

BACKGROUND

Head and neck squamous cell carcinomas (HNSCC) pose significant clinical challenges, particularly in high-risk cases with positive lymph node status. Current prognostic biomarkers are often costly and methodologically demanding. In this regard, histomorphological biomarkers such as tumor buds (TB) and poorly differentiated clusters (PDC) represent promising, cost-effective prognostic indicators that are relatively straightforward to implement.

METHODS

The prognostic significance of TB and PDC, in conjunction with stromal tumor-infiltrating lymphocytes (sTILs) and the tumor-stroma ratio (TSR), was evaluated in a cohort of 50 high-risk, nodal-positive HNSCC patients. Histomorphological features were assessed using standard hematoxylin and eosin (H&E) staining, while HPV association and PD-L1 expression were determined by means of immunohistochemistry (IHC) and/or PCR. All variables collected were subsequently correlated with traditional histopathological and clinical parameters. Finally, a novel scoring system incorporating TB and PDC was developed, and its association with overall survival (OS) was analyzed.

RESULTS

TB and PDC both demonstrated a significant impact on patients' OS (TB Log-rank test, p = 0.0499, PDC Log-rank test, p = 0.0235). A novel scoring system based on these features had strong association with patients' OS (Log-rank test, p = 0.0200) in contrast to the conventional and routinely performed grading system, which evaluates the degree of differentiation within neoplastic cells (Log-rank test, p = 0.3325). PD-L1 expression was not associated with TB and PDC formation. HPV-negative status was associated with a higher number of tumor buds.

CONCLUSION

This study reveals the potential prognostic value of TB and PDC in high-risk HNSCC, which may offer a practical and cost-effective alternative to traditional markers. Our proposed practicable and straightforward employable scoring system significantly correlates with OS, suggesting its potential benefit in clinical practice. These findings advocate for further validation to enhance prognostic accuracy and guide treatment strategies in HNSCC.

摘要

背景

头颈部鳞状细胞癌(HNSCC)带来了重大的临床挑战,尤其是在淋巴结状态为阳性的高危病例中。当前的预后生物标志物往往成本高昂且对方法学要求较高。在这方面,组织形态学生物标志物如肿瘤芽(TB)和低分化簇(PDC)是很有前景的、具有成本效益的预后指标,实施起来相对简单。

方法

在一组50例高危、淋巴结阳性的HNSCC患者中,评估了TB和PDC与基质肿瘤浸润淋巴细胞(sTILs)及肿瘤-基质比(TSR)的预后意义。使用标准苏木精和伊红(H&E)染色评估组织形态学特征,同时通过免疫组织化学(IHC)和/或聚合酶链反应(PCR)确定人乳头瘤病毒(HPV)相关性和程序性死亡受体1配体(PD-L1)表达。随后将收集的所有变量与传统组织病理学和临床参数进行关联分析。最后,开发了一种纳入TB和PDC的新型评分系统,并分析其与总生存期(OS)的关联。

结果

TB和PDC均对患者的OS有显著影响(TB对数秩检验,p = 0.0499;PDC对数秩检验,p = 0.0235)。与评估肿瘤细胞内分化程度的传统常规分级系统(对数秩检验,p = 0.3325)相比,基于这些特征的新型评分系统与患者的OS有很强的关联(对数秩检验,p = 0.0200)。PD-L1表达与TB和PDC的形成无关。HPV阴性状态与更多的肿瘤芽相关。

结论

本研究揭示了TB和PDC在高危HNSCC中的潜在预后价值,这可能为传统标志物提供一种实用且具成本效益的替代方案。我们提出的实用且易于应用的评分系统与OS显著相关,表明其在临床实践中的潜在益处。这些发现主张进一步验证,以提高HNSCC的预后准确性并指导治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa9/11829162/8b45afca10b2/CAM4-14-e70685-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验